MR-148E
RESOURCE MANAGEMENT IN
CHALLENGED
ENVIRONMENTS: NABC 9 CONFERENCE REPORT
Prepared by Sonya Dakers
Science and Technology Division
19 June 1997
TABLE OF CONTENTS
PLENARY
1: AG BIOTECHNOLOGY IN THE 21st CENTURY,
THE PROMISE AND THE PITFALLS
PLENARY II: PERSPECTIVES ON BIOTECHNOLOGY FOR
AGRICULTURE IN CHALLENGED ENVIRONMENTS
PLENARY
III: GLOBAL CHANGE AND AGRICULTURAL PRODUCTION
WORKSHOP 1: BIODIVERSITY CONSERVATION FOR
SUSTAINABLE AGROECOSYSTEMS
WORKSHOP 2: REGULATORY AND ECONOMIC ASPECTS
OF ACCESSING INTERNATIONAL MARKETS
WORKSHOP 3: BIOTECHNOLOGY AND SOCIAL ISSUES
IN RURAL AGRICULTURAL COMMUNITIES
CONCLUDING
PLENARY
RESOURCE
MANAGEMENT IN CHALLENGED ENVIRONMENTS:
NABC 9 CONFERENCE REPORT
The National Biotechnology
Council (NABC) is a consortium of 25 not-for-profit agricultural research and educational
institutions established in 1988. The Council offers an open forum for persons with
different interests and concerns to participate in meaningful dialogue on issues in
agricultural biotechnology.
NABC 9, held 1-3 June 1997, focused
on biotechnologys promise for aiding resource management in challenged environments.
This was a particularly apt topic for the site chosen for the conference, which was
Saskatoon, Saskatchewan. Saskatchewan, which, among other challenges, experiences severe
growing conditions, has made ag biotechnology a centrepiece for economic development
efforts.
Three plenary sessions provided background
information on ag biotechnology developments at the national and international levels. The
forum then broke into three workshops where recommendations were formulated on more
specific aspects of ag biotechnology for presentation to government and private
policymakers.
PLENARY I: AG BIOTECHNOLOGY IN THE 21st CENTURY,
THE PROMISE AND THE PITFALLS
Dr. Robert W. Herdt, Director for
Agricultural Sciences and Acting Director for Global Environment at the Rockefeller
Foundation, highlighted the potential and the limitations of biotechnology in assisting
agriculture to meet the basic needs of an ever-growing human population. He focused on the
work being done in raising productivity, increasing disease and pest resistance, and
promoting sustainable agriculture.
He pointed out, however, that the traits
being developed will help productivity only indirectly since most of the work is being
done on herbicide tolerance. Many of the field trials are being conducted on vegetables
and grains such as canola that are not staples in the developing world, where, indeed,
only about 10% of the field trials are actually being carried out. Of the
$2.5 billion being spent annually on ag biotech, only $75 million is being spent
in the developing world. More research is needed on producing crops that respond to low
soil fertility, drought and salinity.
The second speaker, Mark Winfield,
Director of Research, Canadian Institute for Environmental Law and Policy, argued that
societys perception of the risks associated with biotechnology might tend to limit
its usefulness and expressed the view that public acceptance had not necessarily increased
with understanding. He reported that an Advisory Commission is to be established to assist
the Canadian government in coming to terms with the social and ethical issues involved in
biotech-related decision-making.
Mr. Winfield considered that impact
analysis of biotechnology was tending to lag behind the technology itself. Nor was there
any follow-up or monitoring process once approvals were granted. He questioned whether
biotech applications were related to enhancing food supply or were rather more suited to
serving western industrial agricultural practices. He considered there were some dangers
associated with promoting a form of agriculture that was not only highly dependent on
external inputs but might also have ecological implications. Low tech, which might be a
preferable option, was not being researched to the same extent.
People appeared ready to take certain
risks in relation to pharmaceutical biotech that they were ready to take in relation to
food. According to Mr. Winfield, public confidence in relation to new products depends on
the robustness of the regulatory system. On 15 May 1997, Canada put in place its Novel
Food Regulations to regulate such foods as biotech derivatives.
PLENARY II: PERSPECTIVES ON BIOTECHNOLOGY FOR
AGRICULTURE IN CHALLENGED ENVIRONMENTS
Four speakers spoke on the challenges
to industry, producers, and consumers of producing food under difficult conditions.
Saskatchewan, with 80% of Canadas arable land, supports a multi-billion dollar
agricultural business; however, producers face climatic and geographic challenges. Long,
very cold winters, followed by hot, dry summers and limited precipitation, hinder crop
production. As Saskatchewan is a landlocked province, all agricultural products must be
shipped by truck or rail hundreds or thousands of miles for export. One of the ways in
which Saskatchewan has met these challenges is by becoming an internationally recognized
centre for agricultural research, with a prime emphasis on agricultural biotechnology.
It was reported that technology had
enabled production to overcome diseases, insects, and dryland conditions and would
probably continue to have a role in increasing production. Industry saw biotech as a tool
for creating new products and an engine of growth in which over 500 companies had invested
$1.7 billion in R&D. Revenues were $3.5 billion annually in Canada.
The challenges for the industry are to
find different products to suit different needs, increase public awareness, and ensure
there are enough trained people for the 12,000 new jobs projected for the year 2000.
Another speaker reviewed the biotechnology
regulatory experience in Japan, Australia, and North America. While all three are adapting
their regulatory systems to include new biotech products, North America appears to be
ahead in commercialization and approvals. Public awareness is growing on this continent,
according to surveys conducted, but is still below 25%.
A need for an action plan was identified
that would include designing a national communications strategy for products coming on to
the market, assigning it the resources needed, and finally implementing it. Monitoring
progress would also be necessary. The speaker expressed the view that there was a role for
NABC in all stages of this project.
The last two speakers dealt with the
environmental aspects of biotechnology and its impact on organic farming, and the
environment generally. A Biosafety code is being developed to cover the transboundary
movement of products.
PLENARY III: GLOBAL CHANGE AND AGRICULTURAL PRODUCTION
Professor Reeves, the Director General of
CIMMYT (International Centre for Maize and Wheat Improvement), put the issues under
discussion into a global perspective. CIMMYT has outreach in 16 poor developing countries.
It is concentrating on developing crop technologies that will help under-developed African
and Asian economies. Despite a projected doubling of demand for wheat and maize, spending
on such research is now at $7 billion a year, down from $9 billion in 1981. To
keep up yield efficiency, the need is for robust genetic material that is durable against
diseases. To date, genetic engineering is not being used as much as marker-based
technology. CIMMYT allows free access to its genetic resources and is looking for
partnerships with countries like Canada that have expertise in grains.
WORKSHOP
1: BIODIVERSITY CONSERVATION
FOR SUSTAINABLE AGROECOSYSTEMS
Participants in this workshop examined the
impact of biotechnology products and related new technologies on biodiversity. Not enough
is known about whether biotech methods impede or enhance biodiversity and whether biotech
products could have more impact than conventional systems on such things as
sustainability. For instance, what might be the impact of replacing traditional crops with
new products and in what circumstances might biotech products pose more risks to
biodiversity than conventional strategies? As mentioned, an international protocol is
being negotiated on Biosafety.
It was felt that farmers might tend to use
biotech products if it helped the "bottom line." It was suggested there was a
need to quantify the benefits of biotech for agroecosystems. While the advances were
expected to continue, these would be seen more often in the private sector. Private
ownership might tend to inhibit investment in areas where it was needed, and it was not at
all clear where the requisite funding, for instance, to conserve desirable genetic
resources, would be generated.
To deal with issues such as increasing
understanding, the cost of protecting genetic resources, and accountability, the workshop
recommended:
WORKSHOP
2: REGULATORY AND ECONOMIC ASPECTS
OF ACCESSING INTERNATIONAL MARKETS
Participants in this workshop explored the
consequences of ag biotechnology on marketing products. An examination of regulation at
the international level revealed regulatory disarray. The need for harmonization and
product as opposed to process-based regulatory systems was identified. Labelling was
advocated to encourage consumer acceptance.
Laws and policies (especially in
developing countries) were required to protect intellectual property rights (IPR). Another
concern was instituting a systems approach to R&D that would break down some of the
barriers to coordinating research. The lack of availability of risk capital was seen as a
limitation on proceeding to the commercial stage.
WORKSHOP
3: BIOTECHNOLOGY AND SOCIAL ISSUES
IN RURAL AGRICULTURAL COMMUNITIES
Participants in this workshop evaluated
the impact of adopting new technologies on producers and rural communities. On the one
hand, timely access to new technologies could represent a key to competitiveness for
producers; on the other hand, producers need to have unbiased scientific information in
order to assess any safety or health risks.
It was suggested that case studies of
successful applications and cost-benefit analyses would be helpful. There also needed to
be more public debate and a coordinating mechanism for developing a code of ethics. The
Advisory Commission should presumably be of some help in promoting a dialogue.
CONCLUDING PLENARY
Workshop leaders provided a summary
of discussions at the workshop level. A final summing-up was provided by Eugene G. Sander,
Vice-Provost and Dean of Agriculture, University of Arizona. He commented that making ag
biotechnology work in "challenged environments" was a complex process, and could
not be fixed by merely transferring genes. Responding to the specific needs of developing
countries in such environments did not appear to be as yet well in hand. The jury was
still out on whether biotech was the one or appropriate tool for feeding our
ever-increasing world population; not enough was known about possible unintended results.
The consensus seemed to be that ag
biotechnology was neither good nor bad in its own right, that it was a tool, and that its
usefulness depended on its application. To date, more progress has actually been made in
increasing yield through markers and classical plant breeding than through recombinant
DNA. There is still confusion about the terminology and impacts, and this must be resolved
before solutions become apparent.
|